WHAT FACTORS INFLUENCE THE CHOICE OF APIXABAN, RIVAROXABAN, OR DABIGATRAN FOR STROKE PREVENTION AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE? INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY

WHAT FACTORS INFLUENCE THE CHOICE OF APIXABAN, RIVAROXABAN, OR DABIGATRAN FOR STROKE PREVENTION AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE? INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY

Methods The Stroke Prevention and Rhythm INTerventions in Atrial Fibrillation (SPRINT-AF) registry prospectively enrolled 2,498 patients with non-valvular AF at 132 community-based practices (67% Family Medicine and 33% specialists) in Canada from Nov 2013 to Mar 2016. [...]lower risk of bleeding (a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A521-A521
Hauptverfasser: Ha, Andrew C.T., Labos, Christopher, Kajil, Mahesh, Tsigoulis, Michelle, Cox, Jafna, Mancini, G.B. John, Dorian, Paul, Gladstone, David, Lockwood, Evan, Shuaib, Ashfaq, Chan, William, Singh, Narendra, Gupta, Milan
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiac arrhythmia
Cardiology
Clinical medicine
Fibrillation
Stroke
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods The Stroke Prevention and Rhythm INTerventions in Atrial Fibrillation (SPRINT-AF) registry prospectively enrolled 2,498 patients with non-valvular AF at 132 community-based practices (67% Family Medicine and 33% specialists) in Canada from Nov 2013 to Mar 2016. [...]lower risk of bleeding (as perceived by physicians) was more frequently cited as a reason for selecting apixaban vs. dabigatran or rivaroxaban (30% vs. 10% and 11%, p
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)31062-3